Global Eosinophilic Esophagitis Drug Market Research Report 2024(Status and Outlook)

Global Eosinophilic Esophagitis Drug Market Research Report 2024(Status and Outlook)



Report Overview:

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.

The Global Eosinophilic Esophagitis Drug Market Size was estimated at USD 137.87 million in 2023 and is projected to reach USD 190.10 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.

This report provides a deep insight into the global Eosinophilic Esophagitis Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Eosinophilic Esophagitis Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Eosinophilic Esophagitis Drug market in any manner.

Global Eosinophilic Esophagitis Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca

GSK

Bayer

Adare Pharmaceuticals

DBV Technologies

Dr. Falk Pharma

Quorum Innovations

Takeda

Calypso

Celgene

Regeneron

Market Segmentation (by Type)

Budesonide

Fluticasone

Others

Market Segmentation (by Application)

Hospitals

Clinics

Drugstore

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Eosinophilic Esophagitis Drug Market
  • Overview of the regional outlook of the Eosinophilic Esophagitis Drug Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Eosinophilic Esophagitis Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Eosinophilic Esophagitis Drug
1.2 Key Market Segments
1.2.1 Eosinophilic Esophagitis Drug Segment by Type
1.2.2 Eosinophilic Esophagitis Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Eosinophilic Esophagitis Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Eosinophilic Esophagitis Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Eosinophilic Esophagitis Drug Market Competitive Landscape
3.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturers (2019-2024)
3.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Eosinophilic Esophagitis Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Eosinophilic Esophagitis Drug Sales Sites, Area Served, Product Type
3.6 Eosinophilic Esophagitis Drug Market Competitive Situation and Trends
3.6.1 Eosinophilic Esophagitis Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Eosinophilic Esophagitis Drug Industry Chain Analysis
4.1 Eosinophilic Esophagitis Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Eosinophilic Esophagitis Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Eosinophilic Esophagitis Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2019-2024)
6.3 Global Eosinophilic Esophagitis Drug Market Size Market Share by Type (2019-2024)
6.4 Global Eosinophilic Esophagitis Drug Price by Type (2019-2024)
7 Eosinophilic Esophagitis Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Eosinophilic Esophagitis Drug Market Sales by Application (2019-2024)
7.3 Global Eosinophilic Esophagitis Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Eosinophilic Esophagitis Drug Sales Growth Rate by Application (2019-2024)
8 Eosinophilic Esophagitis Drug Market Segmentation by Region
8.1 Global Eosinophilic Esophagitis Drug Sales by Region
8.1.1 Global Eosinophilic Esophagitis Drug Sales by Region
8.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Eosinophilic Esophagitis Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Eosinophilic Esophagitis Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Eosinophilic Esophagitis Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Eosinophilic Esophagitis Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca
9.1.1 AstraZeneca Eosinophilic Esophagitis Drug Basic Information
9.1.2 AstraZeneca Eosinophilic Esophagitis Drug Product Overview
9.1.3 AstraZeneca Eosinophilic Esophagitis Drug Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Eosinophilic Esophagitis Drug SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 GSK
9.2.1 GSK Eosinophilic Esophagitis Drug Basic Information
9.2.2 GSK Eosinophilic Esophagitis Drug Product Overview
9.2.3 GSK Eosinophilic Esophagitis Drug Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Eosinophilic Esophagitis Drug SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Bayer
9.3.1 Bayer Eosinophilic Esophagitis Drug Basic Information
9.3.2 Bayer Eosinophilic Esophagitis Drug Product Overview
9.3.3 Bayer Eosinophilic Esophagitis Drug Product Market Performance
9.3.4 Bayer Eosinophilic Esophagitis Drug SWOT Analysis
9.3.5 Bayer Business Overview
9.3.6 Bayer Recent Developments
9.4 Adare Pharmaceuticals
9.4.1 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Basic Information
9.4.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Overview
9.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Market Performance
9.4.4 Adare Pharmaceuticals Business Overview
9.4.5 Adare Pharmaceuticals Recent Developments
9.5 DBV Technologies
9.5.1 DBV Technologies Eosinophilic Esophagitis Drug Basic Information
9.5.2 DBV Technologies Eosinophilic Esophagitis Drug Product Overview
9.5.3 DBV Technologies Eosinophilic Esophagitis Drug Product Market Performance
9.5.4 DBV Technologies Business Overview
9.5.5 DBV Technologies Recent Developments
9.6 Dr. Falk Pharma
9.6.1 Dr. Falk Pharma Eosinophilic Esophagitis Drug Basic Information
9.6.2 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Overview
9.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Market Performance
9.6.4 Dr. Falk Pharma Business Overview
9.6.5 Dr. Falk Pharma Recent Developments
9.7 Quorum Innovations
9.7.1 Quorum Innovations Eosinophilic Esophagitis Drug Basic Information
9.7.2 Quorum Innovations Eosinophilic Esophagitis Drug Product Overview
9.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Product Market Performance
9.7.4 Quorum Innovations Business Overview
9.7.5 Quorum Innovations Recent Developments
9.8 Takeda
9.8.1 Takeda Eosinophilic Esophagitis Drug Basic Information
9.8.2 Takeda Eosinophilic Esophagitis Drug Product Overview
9.8.3 Takeda Eosinophilic Esophagitis Drug Product Market Performance
9.8.4 Takeda Business Overview
9.8.5 Takeda Recent Developments
9.9 Calypso
9.9.1 Calypso Eosinophilic Esophagitis Drug Basic Information
9.9.2 Calypso Eosinophilic Esophagitis Drug Product Overview
9.9.3 Calypso Eosinophilic Esophagitis Drug Product Market Performance
9.9.4 Calypso Business Overview
9.9.5 Calypso Recent Developments
9.10 Celgene
9.10.1 Celgene Eosinophilic Esophagitis Drug Basic Information
9.10.2 Celgene Eosinophilic Esophagitis Drug Product Overview
9.10.3 Celgene Eosinophilic Esophagitis Drug Product Market Performance
9.10.4 Celgene Business Overview
9.10.5 Celgene Recent Developments
9.11 Regeneron
9.11.1 Regeneron Eosinophilic Esophagitis Drug Basic Information
9.11.2 Regeneron Eosinophilic Esophagitis Drug Product Overview
9.11.3 Regeneron Eosinophilic Esophagitis Drug Product Market Performance
9.11.4 Regeneron Business Overview
9.11.5 Regeneron Recent Developments
10 Eosinophilic Esophagitis Drug Market Forecast by Region
10.1 Global Eosinophilic Esophagitis Drug Market Size Forecast
10.2 Global Eosinophilic Esophagitis Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Eosinophilic Esophagitis Drug Market Size Forecast by Country
10.2.3 Asia Pacific Eosinophilic Esophagitis Drug Market Size Forecast by Region
10.2.4 South America Eosinophilic Esophagitis Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Eosinophilic Esophagitis Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Eosinophilic Esophagitis Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Eosinophilic Esophagitis Drug by Type (2025-2030)
11.1.2 Global Eosinophilic Esophagitis Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Eosinophilic Esophagitis Drug by Type (2025-2030)
11.2 Global Eosinophilic Esophagitis Drug Market Forecast by Application (2025-2030)
11.2.1 Global Eosinophilic Esophagitis Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Eosinophilic Esophagitis Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings